The unanticipated loss of SO2 from sulfonamides in collision‐induced dissociation
- 26 November 2002
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 17 (1) , 81-86
- https://doi.org/10.1002/rcm.877
Abstract
A potent and selective sulfonamide β3 agonist with an excellent pharmacokinetic profile has recently been synthesized. During the analysis by liquid chromatography/tandem mass spectrometry (LC/MS/MS) of metabolites of the sulfonamide N-{4-[2-(2-hydroxy-2-pyridin-3-ylethylamino)ethyl]phenyl}-4-[4-(4-trifluoromethylphenyl)thiazol-2-yl]benzulfonamide (compound A), we observed loss of 64 Da for a few of the metabolites in the negative ion mode. Accurate mass measurements performed with Fourier transform ion cyclotron resonance (FTICR) mass spectrometry and quadrupole time-of-flight (Q-TOF) mass spectrometry suggested that the loss of 64 Da corresponded to the loss of SO2. The same phenomenon was observed for a group of structurally related and commercially available compounds that also contain a sulfonamide moiety. MS/MS analysis of the fragment ions that had lost SO2 in the ion source suggested that these ions were covalently bound rather than ion-molecule complexes. The neutral loss involving the cleavage of two bonds was unanticipated and suggested a complex rearrangement process. A mechanism for the loss of SO2 has been proposed. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 11 references indexed in Scilit:
- The Pharmacokinetics of a Thiazole Benzenesulfonamide β3-Adrenergic Receptor Agonist and Its Analogs in Rats, Dogs, and Monkeys: Improving Oral BioavailabilityDrug Metabolism and Disposition, 2002
- Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β3-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid ConjugateDrug Metabolism and Disposition, 2002
- Determination of eight sulfonamides in bovine kidney by liquid chromatography/tandem mass spectrometry with on-line extraction and sample clean-upRapid Communications in Mass Spectrometry, 2000
- Discovery of a Potent, Orally Bioavailable β3 Adrenergic Receptor Agonist, (R)-N-[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamideJournal of Medicinal Chemistry, 2000
- The Impact of Drug Metabolism in Contemporary Drug Discovery: New Opportunities and Challenges for Mass SpectrometryPublished by Springer Nature ,2000
- HPLC-API/MS/MS: a powerful tool for integrating drug metabolism into the drug discovery processDrug Discovery Today, 1997
- Comparison of Flow Injection/Thermospray MS/MS and LC/Thermospray MS/MS Methods for Determination of Sulfonamides in Meat and BloodAnalytical Chemistry, 1994
- High-performance liquid chromatographic methods for the determination of sulfonamides in tissue, milk and eggsJournal of Chromatography A, 1992
- Chronic toxicity/carcinogenicity studies of sulphamethazine in Fischer 344/N rats: Two-generation exposureFood and Chemical Toxicology, 1990
- Rapid sample preparation methods for analysis of residues of sulfamethazine and its N4‐acetyl and desamino metabolites in swine tissue by HPLCBiomedical Chromatography, 1987